Condition We Treat
ADHD
Comprehensive evaluation, diagnosis, and medication management for children, teens, and adults — delivered via telehealth across Colorado.
Book a Free 15-Min ConsultationWhat is ADHD?
Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental condition characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with daily functioning and development.
ADHD is one of the most common mental health conditions, affecting approximately 5–10% of children and 4–5% of adults. It is not a character flaw or a result of poor parenting — it is a well-documented neurobiological difference in how the brain regulates attention, motivation, and executive function.
Many adults were never diagnosed as children, particularly women, who often present with predominantly inattentive symptoms that are easier to overlook.
DSM-5 Diagnostic Criteria
A diagnosis requires at least 6 symptoms (5 for adults 17+) from one or both clusters, present for ≥6 months, in two or more settings, with onset before age 12.
Inattention
- Difficulty sustaining attention on tasks or play
- Frequent careless mistakes; poor attention to detail
- Doesn't seem to listen when spoken to directly
- Fails to follow through on instructions
- Difficulty organizing tasks and activities
- Avoids tasks requiring sustained mental effort
- Loses things necessary for tasks
- Easily distracted by extraneous stimuli
- Forgetful in daily activities
Hyperactivity / Impulsivity
- Fidgets, taps hands or feet, squirms in seat
- Leaves seat when expected to remain seated
- Runs or climbs in inappropriate situations
- Unable to play or engage quietly
- Often "on the go," driven by a motor
- Talks excessively
- Blurts out answers before questions are complete
- Difficulty waiting their turn
- Interrupts or intrudes on others
Three presentations of ADHD
As defined in the DSM-5
ADHD-PI
Predominantly Inattentive
Meets criteria for inattention but not hyperactivity-impulsivity. Common in adults and women. Often missed because it presents as daydreaming, forgetfulness, or disorganization rather than disruptive behavior.
ADHD-PH
Predominantly Hyperactive-Impulsive
Meets criteria for hyperactivity-impulsivity but not inattention. More common in young children. Often evolves into the combined presentation as the child ages.
ADHD-C
Combined Presentation
Meets criteria for both inattention and hyperactivity-impulsivity. The most commonly diagnosed presentation across all age groups.
Our evaluation process
A thorough, evidence-based assessment to reach an accurate diagnosis and build a personalized treatment plan.
Initial Intake
A 60–90 minute telehealth appointment covering your full psychiatric, medical, and developmental history. We review prior records and any previous testing.
Symptom Rating Scales
Validated tools such as the Adult ADHD Self-Report Scale (ASRS), Conners scales, or Vanderbilt forms (for children) are completed before or during the visit.
Differential Diagnosis
We rule out conditions that can mimic ADHD — anxiety, depression, sleep disorders, thyroid issues, and learning disabilities — before confirming a diagnosis.
Treatment Planning
If ADHD is confirmed, we discuss medication options, lifestyle strategies, and any referrals for therapy or neuropsychological testing if indicated.
Medication options
We work with you to find the right fit — not a one-size-fits-all approach
Stimulant Medications
First-line treatment
Stimulants are the most studied and effective medications for ADHD, with decades of safety data. They work by increasing dopamine and norepinephrine availability in the prefrontal cortex, improving focus, impulse control, and working memory. Effects are typically felt within the first dose.
Methylphenidate-based
Ritalin, Concerta, Focalin, Jornay PM
Available in short- and long-acting formulations. Often preferred for children.
Amphetamine-based
Adderall, Vyvanse, Dexedrine, Evekeo
Generally more potent per milligram. Vyvanse is a prodrug with lower abuse potential.
Non-Stimulant Medications
Alternative & adjunct options
Non-stimulants are preferred when stimulants are not tolerated, there is a history of substance use disorder, significant anxiety, tics, or cardiac concerns. They take 4–8 weeks to reach full effect but provide smooth, 24-hour coverage without peaks and troughs.
Atomoxetine (Strattera)
Selective norepinephrine reuptake inhibitor. FDA-approved for children and adults. Also helps with anxiety.
Guanfacine (Intuniv) & Clonidine (Kapvay)
Alpha-2 agonists. Particularly useful for hyperactivity, impulsivity, and tics. Often used as adjuncts.
Bupropion (Wellbutrin)
Off-label but well-supported. Useful when ADHD co-occurs with depression or when stimulants are contraindicated.
Viloxazine (Qelbree)
Newer FDA-approved non-stimulant for children 6–17. Selective norepinephrine reuptake inhibitor.
Frequently asked questions
Ready to get evaluated?
Book a free 15-minute consultation to discuss your symptoms and learn how we can help.